Zacks Investment ResearchFri, 08 May 2026 17:56:19 GMTNektar Q1 Earnings & Revenues Lag Estimates, Pipeline in FocusNKTR-1.31%
Seeking AlphaFri, 08 May 2026 09:11:18 GMTNektar Therapeutics (NKTR) Q1 2026 Earnings Call TranscriptNKTR-1.31%
Seeking AlphaTue, 05 May 2026 14:24:29 GMTNektar Therapeutics: This Stock Went Up 10x In The Last Year And It's Still CheapNKTR-1.31%
Zacks Investment ResearchTue, 21 Apr 2026 15:41:14 GMTNektar (NKTR) Moves 18.3% Higher: Will This Strength Last?NKTR-1.31%
Seeking AlphaMon, 20 Apr 2026 20:17:24 GMTNektar Therapeutics: 'Strong Buy' On REZPEG POC Established In AD/AA And Late-Stage DevelopmentNKTR-1.31%
Seeking AlphaMon, 20 Apr 2026 17:41:44 GMTNektar Therapeutics (NKTR) Discusses 52-Week Topline Results From REZOLVE-AA Phase 2b Extension in Severe Alopecia Areata TranscriptNKTR-1.31%
Investors Business DailyMon, 20 Apr 2026 16:40:47 GMTNektar Therapeutics Adds To Its 129% Two-Month Run With Alopecia NewsNKTR-1.31%
BarronsMon, 20 Apr 2026 15:43:00 GMTThis Biotech Stock Soars on Hair Loss Trial Results. It's Not a Cure for Baldness.NKTR-1.31%
Seeking AlphaWed, 15 Apr 2026 13:03:22 GMTNektar Therapeutics Upcoming AA Data Prediction: Why I Think It Will Be PositiveNKTR-1.31%
Zacks Investment ResearchThu, 05 Mar 2026 16:01:16 GMTAnalysts Estimate Nektar Therapeutics (NKTR) to Report a Decline in Earnings: What to Look Out forNKTR-1.31%
Zacks Investment ResearchWed, 25 Feb 2026 15:57:16 GMTWall Street Analysts Think Nektar (NKTR) Could Surge 89.8%: Read This Before Placing a BetNKTR-1.31%
